NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing insightful information on the chemical properties of the compounds we supply. Cytidine-5'-diphosphate disodium salt, identified by its CAS number 54394-90-0, is a fascinating molecule with specific and crucial chemical reactivity, making it a sought-after intermediate.

The primary reactivity of Cytidine-5'-diphosphate disodium salt lies in its role as a substrate in enzymatic reactions. Specifically, it is phosphorylated by CDP kinase to yield CTP (Cytidine Triphosphate). This transformation is a key event in the cytidine-5'-diphosphate disodium salt biosynthesis pathway, directly fueling the production of RNA. Understanding this enzymatic transformation is vital for researchers working on nucleic acid metabolism and related cellular processes.

In addition to its role in CTP synthesis, Cytidine-5'-diphosphate disodium salt also undergoes reduction by nucleoside reductase to form DCMP (deoxycytidine monophosphate). This reaction is a critical step in the synthesis of DNA precursors. The precise control over these reactions, enabled by the inherent chemical properties of cytidine-5'-diphosphate disodium salt CAS 54394-90-0, allows for targeted manipulation of cellular processes in research and therapeutic development.

As a reliable cytidine-5'-diphosphate disodium salt chemical intermediate, its structure is designed for efficient interaction with specific enzymes. NINGBO INNO PHARMCHEM CO.,LTD. ensures that the product's chemical integrity is maintained from manufacturing to delivery, so researchers can confidently explore its reactivity. When you buy Cytidine-5'-diphosphate disodium salt, you are acquiring a molecule engineered for specific biochemical transformations.

Our commitment is to facilitate scientific advancement by providing essential chemical building blocks. For those needing to harness the specific chemical reactivity of cytidine-5'-diphosphate disodium salt, NINGBO INNO PHARMCHEM CO.,LTD. offers competitive price and reliable purchase channels, ensuring accessibility for all critical research needs.